For instance, the presence of susceptibility alleles at the 1722, 1661, and 318 promoter positions of CTLA-4 did not demonstrate a significant relationship with a graft versus host disease (GVHD) incidence, or disease recurrence [29]. The gene discussed is CTLA4; the disease is graft versus host disease.